Back to 
BlackRock, Inc.
BlackRock, Inc.
QNCX1 quarters
Position history for BlackRock, Inc.'s holdings in QUINCE THERAPEUTICS INC
Yes. BlackRock holds 1,702 shares of QNCX (Quince Therapeutics), worth $30,959, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$30,959
Current Shares
1,702
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of QNCX: BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, UBS Group AG